Profile - To The Moon

WeLian

Posts · 351Posts · 351
Following · 0Following · 0
Followers · 0Followers · 0

- WeLianWeLian
  ·09-23
  Stupid idea ! What you need to do is to relinguish your position as CEO and let an American to take the helm.
  Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT
  UPDATE 1-Novo Nordisk open to direct New York listing, CEO Doustdar tells FTSept 23 (Reuters)-Novo NordiskNOVOb.COis open to considering a direct New York Stock Exchange listing, replacing the America
  Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT
  208 Comment
  3
  Share
  Report
- WeLianWeLian
  ·09-04
  $Novo-Nordisk A/S(NVO)$ This stock is too speculative. I'm out !
  1.07K 1
  2
  Share
  Report
- WeLianWeLian
  ·08-27
  $Novo-Nordisk A/S(NVO)$ Luckily sold my shares.
  680 Comment
  2
  Share
  Report
- WeLianWeLian
  ·08-21
  ‌$Tiger Brokers(TIGR)$ ‌To the moon ya...
  798 Comment
  2
  Share
  Report
- WeLianWeLian
  ·07-23
  $Novo-Nordisk A/S(NVO)$ Queue at $40
  1.11K Comment
  1
  Share
  Report
- WeLianWeLian
  ·07-22
  ‌$Tiger Brokers(TIGR)$ ‌‌$Novo-Nordisk A/S(NVO)$ ‌‌To the moon !‌‌
  1.28K Comment
  3
  Share
  Report
- WeLianWeLian
  ·06-22
  ‌This stock sucks !
  1.13K Comment
  Like
  Share
  Report
- WeLianWeLian
  ·06-18
  ‌$Xiaomi Corp.(XIACY)$ ‌‌$Novo-Nordisk A/S(NVO)$ ‌‌$Tiger Brokers(TIGR)$ ‌OMG, bleeding non stop !
  1.47K Comment
  Like
  Share
  Report
- WeLianWeLian
  ·06-18
  ‌$Xiaomi Corp.(XIACY)$ ‌‌$Novo-Nordisk A/S(NVO)$ ‌‌$Tiger Brokers(TIGR)$ ‌OMG, bleeding non stop !
  1.90K Comment
  1
  Share
  Report
- WeLianWeLian
  ·06-18
  Majority of the stocks went up except NoVo
  1.83K Comment
  Like
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3582873342253784","uuid":"3582873342253784","gmtCreate":1619780467374,"gmtModify":1710857955256,"name":"WeLian","pinyin":"welian","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":33,"headSize":13,"tweetSize":351,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.48%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.98%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":610909850804512,"gmtCreate":1790167334341,"gmtModify":1790167853713,"author":{"id":"3582873342253784","authorId":"3582873342253784","name":"WeLian","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582873342253784","idStr":"3582873342253784"},"themes":[],"title":"","htmlText":"Stupid idea ! What you need to do is to relinguish your position as CEO and let an American to take the helm.","listText":"Stupid idea ! What you need to do is to relinguish your position as CEO and let an American to take the helm.","text":"Stupid idea ! What you need to do is to relinguish your position as CEO and let an American to take the helm.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/610909850804512","repostId":"2669177534","repostType":2,"repost":{"id":"2669177534","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1790151673,"share":"https://ttm.financial/m/news/2669177534?lang=en_US&edition=fundamental","pubTime":"2026-09-23 16:21","market":"us","language":"en","title":"Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT","url":"https://stock-news.laohu8.com/highlight/detail?id=2669177534","media":"Reuters","summary":"UPDATE 1-Novo Nordisk open to direct New York listing, CEO Doustdar tells FTSept 23 (Reuters)-Novo NordiskNOVOb.COis open to considering a direct New York Stock Exchange listing, replacing the America","content":"<html><head></head><body><p style=\"text-align: left;\">Novo Nordisk is open to considering a direct New York Stock Exchange listing, replacing the American depositary receipts through which US investors currently trade its shares, CEO Mike Doustdar told the Financial Times in an interview published on Wednesday.</p><p style=\"text-align: left;\">The US accounts for more than half of Novo&#39;s revenue and the bulk of sales of its diabetes and obesity drugs, but the Danish drugmaker is under pressure to regain momentum in the weight-loss market against rival Eli Lilly.</p><p style=\"text-align: left;\">&#34;I clearly do see some advantages with that,&#34; Doustdar told the newspaper when asked whether Novo would consider a direct listing on the New York Stock Exchange.</p><p style=\"text-align: left;\">&#34;Our investor community to a larger extent has shifted over the last 20 years (outside of) Scandinavia, and we are increasingly speaking to investors in the US. . . in addition to (our long-term investors),&#34; Doustdar added.</p><p style=\"text-align: left;\">Doustdar said the idea of a direct US listing had been discussed over the past decade, but there had been no &#34;active dialogue or discussions&#34; about it since he became CEO last year.</p><p style=\"text-align: left;\">&#34;I’m a type who doesn’t start with a &#39;no&#39; typically; I start with &#39;maybe. &#34;Can you give me the pros and the cons of that and let’s have a dialogue and discussions about it,&#34; Doustdar also said, though he stressed that the company is not currently exploring the idea.</p><p style=\"text-align: left;\">Novo, which is primarily listed in Copenhagen, rode a wave of demand after launching weight-loss drug Wegovy in 2021, helping it become Europe&#39;s most valuable listed firm in 2023 with a market value of more than $600 billion.</p><p style=\"text-align: left;\">Novo Nordisk didn&#39;t immediately respond to a Reuters request to comment outside regular business hours.</p><p style=\"text-align: left;\">Since then, however, Novo&#39;s shares have fallen more than 70% since its peak, while Lilly&#39;s have risen. Sales of Lilly&#39;s rival weight-loss treatment, Zepbound, are expected to exceed Wegovy sales this year by more than $7 billion, according to LSEG data.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-09-23 16:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p style=\"text-align: left;\">Novo Nordisk is open to considering a direct New York Stock Exchange listing, replacing the American depositary receipts through which US investors currently trade its shares, CEO Mike Doustdar told the Financial Times in an interview published on Wednesday.</p><p style=\"text-align: left;\">The US accounts for more than half of Novo&#39;s revenue and the bulk of sales of its diabetes and obesity drugs, but the Danish drugmaker is under pressure to regain momentum in the weight-loss market against rival Eli Lilly.</p><p style=\"text-align: left;\">&#34;I clearly do see some advantages with that,&#34; Doustdar told the newspaper when asked whether Novo would consider a direct listing on the New York Stock Exchange.</p><p style=\"text-align: left;\">&#34;Our investor community to a larger extent has shifted over the last 20 years (outside of) Scandinavia, and we are increasingly speaking to investors in the US. . . in addition to (our long-term investors),&#34; Doustdar added.</p><p style=\"text-align: left;\">Doustdar said the idea of a direct US listing had been discussed over the past decade, but there had been no &#34;active dialogue or discussions&#34; about it since he became CEO last year.</p><p style=\"text-align: left;\">&#34;I’m a type who doesn’t start with a &#39;no&#39; typically; I start with &#39;maybe. &#34;Can you give me the pros and the cons of that and let’s have a dialogue and discussions about it,&#34; Doustdar also said, though he stressed that the company is not currently exploring the idea.</p><p style=\"text-align: left;\">Novo, which is primarily listed in Copenhagen, rode a wave of demand after launching weight-loss drug Wegovy in 2021, helping it become Europe&#39;s most valuable listed firm in 2023 with a market value of more than $600 billion.</p><p style=\"text-align: left;\">Novo Nordisk didn&#39;t immediately respond to a Reuters request to comment outside regular business hours.</p><p style=\"text-align: left;\">Since then, however, Novo&#39;s shares have fallen more than 70% since its peak, while Lilly&#39;s have risen. Sales of Lilly&#39;s rival weight-loss treatment, Zepbound, are expected to exceed Wegovy sales this year by more than $7 billion, according to LSEG data.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IYH":"iShares U.S. Healthcare ETF","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","JDOC":"JPMORGAN HEALTHCARE LEADERS ETF","IHE":"iShares U.S. Pharmaceuticals ETF","NVOH":"Novo Nordisk A/S B Shares ADRhedged","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","PPH":"VanEck Pharmaceutical ETF","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","NVOX":"2倍做多NVO ETF-Defiance","TMED":"T. Rowe Price Health Care ETF","CANC":"TEMA ONCOLOGY ETF","MEDI":"HARBOR HEALTH CARE ETF","IE00BJJMRY28.SGD":"Janus Henderson Balanced A Inc SGD","PJP":"INVESCO PHARMACEUTICALS ETF","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","MEDX":"HORIZON KINETICS MEDICAL ETF","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","NVOC":"Corgi NVO 2x Daily ETF","BK4534":"瑞士信贷持仓","GDOC":"Goldman Sachs Future Health Care Equity ETF","MHIP":"Milliman Healthcare Inflation Plus ETF","FHLC":"Fidelity MSCI Health Care Index","VHT":"Vanguard Health Care ETF","SGXZ99366536.SGD":"United Global Innovation A Acc SGD-H","RXL":"ProShares Ultra Health Care","CURE":"Direxion Daily Healthcare Bull 3X ETF","ILDR":"First Trust Innovation Leaders ETF","LLYZ":"2倍做空LLY ETF-Defiance","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","WDNA":"WisdomTree BioRevolution Fund","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","TRUH":"VanEck Healthcare TruSector ETF","THNR":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","OZEM":"Roundhill GLP-1 & Weight Loss ETF","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","IXJ":"全球医疗业ETF-iShares","HRTS":"Tema Heart & Health ETF","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU2168564065.EUR":"AZ ALLOCATION - TREND \"AAZ\" (EUR) ACC","XLV":"健康照护类股ETF-SPDR","FTXH":"First Trust Nasdaq Pharmaceuticals ETF","LU2471134796.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) INC","NVO":"诺和诺德","LU0133085943.USD":"T ROWE PRICE US BLUE CHIP EQUITY \"A\" ACC","AGNG":"Global X Aging Population ETF","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F05A:2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2669177534","content_text":"Novo Nordisk is open to considering a direct New York Stock Exchange listing, replacing the American depositary receipts through which US investors currently trade its shares, CEO Mike Doustdar told the Financial Times in an interview published on Wednesday.The US accounts for more than half of Novo's revenue and the bulk of sales of its diabetes and obesity drugs, but the Danish drugmaker is under pressure to regain momentum in the weight-loss market against rival Eli Lilly.\"I clearly do see some advantages with that,\" Doustdar told the newspaper when asked whether Novo would consider a direct listing on the New York Stock Exchange.\"Our investor community to a larger extent has shifted over the last 20 years (outside of) Scandinavia, and we are increasingly speaking to investors in the US. . . in addition to (our long-term investors),\" Doustdar added.Doustdar said the idea of a direct US listing had been discussed over the past decade, but there had been no \"active dialogue or discussions\" about it since he became CEO last year.\"I’m a type who doesn’t start with a 'no' typically; I start with 'maybe. \"Can you give me the pros and the cons of that and let’s have a dialogue and discussions about it,\" Doustdar also said, though he stressed that the company is not currently exploring the idea.Novo, which is primarily listed in Copenhagen, rode a wave of demand after launching weight-loss drug Wegovy in 2021, helping it become Europe's most valuable listed firm in 2023 with a market value of more than $600 billion.Novo Nordisk didn't immediately respond to a Reuters request to comment outside regular business hours.Since then, however, Novo's shares have fallen more than 70% since its peak, while Lilly's have risen. Sales of Lilly's rival weight-loss treatment, Zepbound, are expected to exceed Wegovy sales this year by more than $7 billion, according to LSEG data.","news_type":1,"symbols_score_info":{"PPH":0.6,"FTXH":0.6,"NVO":2,"RXL":0.6,"LLYZ":0.6,"CURE":0.6,"FHLC":0.6,"CANC":0.6,"TMED":0.6,"GDOC":0.6,"ILDR":0.6,"IXJ":0.6,"WDNA":0.6,"NVOX":0.6,"MEDX":0.6,"JDOC":0.6,"XLV":0.6,"IHE":0.6,"PJP":0.6,"NVOH":0.6,"OZEM":0.6,"TRUH":0.6,"HRTS":0.6,"MEDI":0.6,"VHT":0.6,"AGNG":0.6,"MHIP":0.6,"NVOC":0.6,"THNR":0.6,"IYH":0.6}},"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":604053910816008,"gmtCreate":1788511090135,"gmtModify":1788511093378,"author":{"id":"3582873342253784","authorId":"3582873342253784","name":"WeLian","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582873342253784","idStr":"3582873342253784"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a> This stock is too speculative. I'm out !&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a> This stock is too speculative. I'm out !&nbsp;","text":"$Novo-Nordisk A/S(NVO)$ This stock is too speculative. I'm out !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/604053910816008","isVote":1,"tweetType":1,"viewCount":1072,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":601238189814224,"gmtCreate":1787823731285,"gmtModify":1787823734470,"author":{"id":"3582873342253784","authorId":"3582873342253784","name":"WeLian","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582873342253784","idStr":"3582873342253784"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a> Luckily sold my shares.&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a> Luckily sold my shares.&nbsp;","text":"$Novo-Nordisk A/S(NVO)$ Luckily sold my shares.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/601238189814224","isVote":1,"tweetType":1,"viewCount":680,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":599129672188984,"gmtCreate":1787313628520,"gmtModify":1787316972888,"author":{"id":"3582873342253784","authorId":"3582873342253784","name":"WeLian","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582873342253784","idStr":"3582873342253784"},"themes":[],"title":"","htmlText":"‌<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ &nbsp;</a>‌To the moon ya...","listText":"‌<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ &nbsp;</a>‌To the moon ya...","text":"‌$Tiger Brokers(TIGR)$ ‌To the moon ya...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/599129672188984","isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":588875588821040,"gmtCreate":1784798539994,"gmtModify":1784798543300,"author":{"id":"3582873342253784","authorId":"3582873342253784","name":"WeLian","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582873342253784","idStr":"3582873342253784"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a> Queue at&nbsp; $40","listText":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a> Queue at&nbsp; $40","text":"$Novo-Nordisk A/S(NVO)$ Queue at $40","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/588875588821040","isVote":1,"tweetType":1,"viewCount":1106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":588595862376976,"gmtCreate":1784730354996,"gmtModify":1784731585212,"author":{"id":"3582873342253784","authorId":"3582873342253784","name":"WeLian","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582873342253784","idStr":"3582873342253784"},"themes":[],"title":"","htmlText":"‌<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ &nbsp;</a>‌‌<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ &nbsp;</a>‌‌To the moon !‌‌","listText":"‌<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ &nbsp;</a>‌‌<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ &nbsp;</a>‌‌To the moon !‌‌","text":"‌$Tiger Brokers(TIGR)$ ‌‌$Novo-Nordisk A/S(NVO)$ ‌‌To the moon !‌‌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/588595862376976","isVote":1,"tweetType":1,"viewCount":1277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":577983292629664,"gmtCreate":1782134117485,"gmtModify":1782134120379,"author":{"id":"3582873342253784","authorId":"3582873342253784","name":"WeLian","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582873342253784","idStr":"3582873342253784"},"themes":[],"title":"","htmlText":"‌This stock sucks !","listText":"‌This stock sucks !","text":"‌This stock sucks !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/577983292629664","isVote":1,"tweetType":1,"viewCount":1127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":576571220734336,"gmtCreate":1781789260321,"gmtModify":1781789926807,"author":{"id":"3582873342253784","authorId":"3582873342253784","name":"WeLian","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582873342253784","idStr":"3582873342253784"},"themes":[],"title":"","htmlText":"‌<a href=\"https://ttm.financial/S/XIACY\">$Xiaomi Corp.(XIACY)$ &nbsp;</a>‌‌<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ &nbsp;</a>‌‌<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ &nbsp;</a>‌OMG, bleeding non stop !","listText":"‌<a href=\"https://ttm.financial/S/XIACY\">$Xiaomi Corp.(XIACY)$ &nbsp;</a>‌‌<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ &nbsp;</a>‌‌<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ &nbsp;</a>‌OMG, bleeding non stop !","text":"‌$Xiaomi Corp.(XIACY)$ ‌‌$Novo-Nordisk A/S(NVO)$ ‌‌$Tiger Brokers(TIGR)$ ‌OMG, bleeding non stop !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/576571220734336","isVote":1,"tweetType":1,"viewCount":1473,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":576571237306368,"gmtCreate":1781789260300,"gmtModify":1781789926566,"author":{"id":"3582873342253784","authorId":"3582873342253784","name":"WeLian","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582873342253784","idStr":"3582873342253784"},"themes":[],"title":"","htmlText":"‌<a href=\"https://ttm.financial/S/XIACY\">$Xiaomi Corp.(XIACY)$ &nbsp;</a>‌‌<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ &nbsp;</a>‌‌<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ &nbsp;</a>‌OMG, bleeding non stop !","listText":"‌<a href=\"https://ttm.financial/S/XIACY\">$Xiaomi Corp.(XIACY)$ &nbsp;</a>‌‌<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ &nbsp;</a>‌‌<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ &nbsp;</a>‌OMG, bleeding non stop !","text":"‌$Xiaomi Corp.(XIACY)$ ‌‌$Novo-Nordisk A/S(NVO)$ ‌‌$Tiger Brokers(TIGR)$ ‌OMG, bleeding non stop !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/576571237306368","isVote":1,"tweetType":1,"viewCount":1897,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":576546512065344,"gmtCreate":1781783348977,"gmtModify":1781783351838,"author":{"id":"3582873342253784","authorId":"3582873342253784","name":"WeLian","avatar":"https://community-static.tradeup.com/news/cdbf05a867d3f968294518922f7258d2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582873342253784","idStr":"3582873342253784"},"themes":[],"title":"","htmlText":"Majority of the stocks went up except NoVo","listText":"Majority of the stocks went up except NoVo","text":"Majority of the stocks went up except NoVo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/576546512065344","isVote":1,"tweetType":1,"viewCount":1834,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}